Top 5 Challenges of COVID-19 Vaccine Distribution

Home > > Top 5 Challenges of COVID-19 Vaccine Distribution
December 12, 2021

Ever since the COVID-19 pandemic started in January 2020, the whole world has been waiting with bated breath for a cure or a vaccine. The wait ended towards the end of 2020 with various vaccines getting approvals. With the COVID-19 vaccines already in circulation, their transportation and distribution generates a new set of challenges.

The Pfizer and Moderna COVID-19 vaccines require extremely low temperatures and ultra-freezers for long-term storage. The other vaccines, too, require cold storage and freezers for transportation and distribution. Here are the challenges associated with storing and transporting these vaccines on a global scale.

<strong>1. Sheer Volume of COVID-19 Vaccine Distribution</strong>

While medicines and vaccines have been previously transported over long distances, the sheer volume of the distribution of the COVID-19
vaccine is unheard of. Countries of the GCC, such as the UAE and KSA, have vowed to vaccinate everyone, but when you begin to calculate exactly
how many people that would mean, the required amount of vaccines needed adds up to a huge number.

The population of the GCC is around 65.5 million, and each person requires two doses, making the estimated number of vaccines needed to
vaccinate the whole population roughly 131 million. Europe would need around 890 million doses, whereas the US would need 640 million
doses.

Handling the transportation of such a large volume of precious drugs needs smart solutions that offer continuous tracking and excellent
packaging solutions.

2. Cold Chain Logistics of COVID-19 Vaccine

COVID-19 vaccines require ultra-temperatures during transportation and storage. While cold chain logistics exist, those that can provide such low temperatures at a large scale are not very common.

The temperatures need to be maintained at the required level throughout the transportation and storage phases. The packages being
transported require packing solutions that are both strictly temperature-controlled and also keep the delicate vials of the vaccine safe during
transit.

While these temperature-controlled packaging solutions do exist, most of them rely on high-grade freezers and dry ice. All of these increase the
overall weight of the product to be transported.

Aramex offers various packaging solutions that are ideal for transporting COVID-19 vaccines, making use of inner absorbent materials, seal-
proof bags, and PCM thermal boxes, as well as providing pharmaceutical packaging solutions, such as thermal blankets for pallets, Envirotainers,
and SkyCell containers.

We also offer real-time temperature monitoring to ensure that the vaccines always stay at temperatures between -60°C and 8°C.

Tags :
COVID-19 Vaccine